Replies to post #79463 on Biotech Values

[DewDiligence]

MNTA Insider Shareholdings

[Updated for SEC filings through 9/16/09. The tallies
below include both ordinary and restricted shares
and both vested and non-vested options.]

 
 Executive Officers 
 *Craig Wheeler, CEO        412,344 shares   575,000 options 
 G. Venkataraman, SVP R&D   465,340 shares   163,200 options 
 Steven Brugger, COO        280,089 shares   185,556 options 
 *John Bishop, SVP Pharma    43,047 shares   186,163 options 
 Bruce Leicher, Gen Counsel  29,653 shares   113,300 options 
 James Roach, CMO             9,500 shares   181,500 options 
 *Richard Shea, CFO          33,432 shares   225,450 options 
 =====                    =========        ========= 
 7 Executive Officers     1,273,405 shares 1,630,169 options 
  
  
 Non-executive Directors 
 John Clarke                 77,123 shares   111,000 options 
 Alan Crane                 578,602 shares    88,600 options 
 Bruce Downey†                    0 shares    30,000 options 
 Marsha Fanucci                   0 shares   111,000 options	 
 Peter Hutt                  67,863 shares   186,500 options 
 *Ram Sasisekharan          406,344 shares   111,000 options 
 *Bennett Shapiro             7,000 shares   125,450 options 
 Elizabeth Stoner                 0 shares    64,200 options 
 James Sulat‡                     0 shares    45,000 options 
 =====                    =========          ======= 
 9 Non-executive Dirctrs  1,136,932 shares   872,750 options 
  
  
 All Officers/Directors   2,410,337 shares 2,502,919 options  
  
 *10b5-1 selling plan in effect. 
 †Joined BoD 6/11/09. 
 ‡Joined BoD 6/5/08.